162 related articles for article (PubMed ID: 23174406)
1. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis.
Yang S; Zhang J; Feng C; Huang G
Metabolism; 2013 Apr; 62(4):586-94. PubMed ID: 23174406
[TBL] [Abstract][Full Text] [Related]
2. Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.
Xiong X; Lin XK; Xiao X; Qin DP; Zhou DY; Hu JG; Liu Y; Zhong XS
Nephrology (Carlton); 2016 Jan; 21(1):5-12. PubMed ID: 26072975
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.
Zhou TB; Drummen GP; Jiang ZP; Li HY
Ren Fail; 2015; 37(8):1247-59. PubMed ID: 26161693
[TBL] [Abstract][Full Text] [Related]
4. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.
Sun J; Xu Y; Zhu Y; Lu H
Diabetes Res Clin Pract; 2004 Jun; 64(3):185-90. PubMed ID: 15126006
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.
Guan H; Xia MD; Wang M; Guan YJ; Lyu XC
Medicine (Baltimore); 2020 Aug; 99(35):e21558. PubMed ID: 32871871
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to diabetic nephropathy in Chinese type 2 diabetic patients: a meta-analysis.
Chang WW; Zhang L; Yao YS; Su H; Jin YL; Chen Y
Ren Fail; 2013 Aug; 35(7):1038-43. PubMed ID: 23822721
[TBL] [Abstract][Full Text] [Related]
8. Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in a Chinese population?
Cui WP; Du B; Jia Y; Zhou WH; Liu SM; Cui YC; Ma FZ; Luo P; Miao LN
Arch Med Res; 2012 Jan; 43(1):42-50. PubMed ID: 22209973
[TBL] [Abstract][Full Text] [Related]
9. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
Yan Y; Han F; Fu H; Xia W; Qin X
Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
[TBL] [Abstract][Full Text] [Related]
10. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
[TBL] [Abstract][Full Text] [Related]
11. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies.
Wu YL; Ding XX; Sun YH; Yang HY; Chen J; Zhao X; Jiang YH; Lv XL; Wu ZQ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():78-85. PubMed ID: 23831680
[TBL] [Abstract][Full Text] [Related]
12. The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients.
Tomić NG; Marusić S; Bozikov V; Kusec R; Bacić-Vrca V; Tadić M
Coll Antropol; 2013 Sep; 37(3):789-93. PubMed ID: 24308218
[TBL] [Abstract][Full Text] [Related]
13. Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs.
Nemr R; Salman RA; Jawad LH; Juma EA; Keleshian SH; Almawi WY
Clin Chem Lab Med; 2010 Aug; 48(8):1091-4. PubMed ID: 20524928
[TBL] [Abstract][Full Text] [Related]
14. Interaction of MTHFR C677T polymorphism with smoking in susceptibility to diabetic nephropathy in Chinese men with type 2 diabetes.
Ma L; Jiang Y; Kong X; Liu Q; Zhao H; Zhao T; Cao Y; Li P
J Hum Genet; 2019 Jan; 64(1):23-28. PubMed ID: 30397262
[TBL] [Abstract][Full Text] [Related]
15. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
16. Association of MTHFR 677T variant allele with risk of intracerebral haemorrhage: a meta-analysis.
Gao S; Li H; Xiao H; Yao G; Shi Y; Wang Y; Zhou X; Yu H
J Neurol Sci; 2012 Dec; 323(1-2):40-5. PubMed ID: 22938732
[TBL] [Abstract][Full Text] [Related]
17. Association between end-stage diabetic nephropathy and MTHFR (C677T and A1298C) gene polymorphisms.
Ramanathan G; Harichandana B; Kannan S; Elumalai R; Sfd P
Nephrology (Carlton); 2019 Feb; 24(2):155-159. PubMed ID: 29227003
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
19. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
20. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]